Modulation of laboratory parameters after therapeutic and prophylactic administration of Sandoparin.
Hoppensteadt
D A
DA
Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
Haas
S
S
Breddin
H K
HK
Fareed
J
J
D005342:Fibrinolysis / Q000187:drug effects*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy
D006495:Heparin, Low-Molecular-Weight; C089749:Sandoparin